Status:
ACTIVE_NOT_RECRUITING
The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes
Lead Sponsor:
Loma Linda University
Collaborating Sponsors:
National Mango Board
Conditions:
Hyperglycemia
Dyslipidemias
Eligibility:
All Genders
40-60 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to test the effect of 12 weeks of 1.5 cups per day of fresh mango on glucose control, insulin resistance, lipids, inflammation, oxidation and body composition in ind...
Eligibility Criteria
Inclusion
- HgbA1c of 5.7 to 6.4% indicative of prediabetes
- Abdominal obesity as defined as a waist circumference \>102 cm for men or \>88 cm for women
Exclusion
- Self-reported chronic disease history (diabetes, heart disease, cancer, kidney disease, inflammatory bowel disease, etc.)
- Pacemaker
- Mango allergies
- Latex allergies (cross-reactive with mango)
- Smoking, use of tobacco, or high alcohol intake (\>2 drinks/day for men or \>1 drink per day for women)
- Recent significant weight loss (\>5% within 6 months of study enrollment)
- BMI \>35 kg/m\^2
- Pregnancy or lactation
- Use of medication and/or supplements affecting glycemic indicators or lipids
- Habitual mango intake of \>3 servings per week and/or habitual fruit intake of \>2 servings per day
- Not able to read and/or communicate in English
Key Trial Info
Start Date :
July 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT06159543
Start Date
July 30 2024
End Date
July 1 2026
Last Update
October 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nutrition Research Center, School of Public Health, Loma Linda University
Loma Linda, California, United States, 92350